25 XP   0   0   10

Genomictree Inc.
Buy, Hold or Sell?

Let's analyse Genomictree Inc. together

PenkeI guess you are interested in Genomictree Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genomictree Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genomictree Inc.

I send you an email if I find something interesting about Genomictree Inc..

Quick analysis of Genomictree Inc. (30 sec.)










What can you expect buying and holding a share of Genomictree Inc.? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩5,290.79
Expected worth in 1 year
₩5,371.96
How sure are you?
41.2%

+ What do you gain per year?

Total Gains per Share
₩81.17
Return On Investment
0.4%

For what price can you sell your share?

Current Price per Share
₩22,800.00
Expected price per share
₩17,570 - ₩27,950
How sure are you?
50%

1. Valuation of Genomictree Inc. (5 min.)




Live pricePrice per Share (EOD)

₩22,800.00

Intrinsic Value Per Share

₩-5,646.15 - ₩-6,608.59

Total Value Per Share

₩-355.36 - ₩-1,317.81

2. Growth of Genomictree Inc. (5 min.)




Is Genomictree Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$87.5m$82.8m$1.1m1.4%

How much money is Genomictree Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$1.1m-$439.7k-27.5%
Net Profit Margin-292.0%-344.9%--

How much money comes from the company's main activities?

3. Financial Health of Genomictree Inc. (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#229 / 394

Most Revenue
#370 / 394

Most Profit
#328 / 394

Most Efficient
#384 / 394

What can you expect buying and holding a share of Genomictree Inc.? (5 min.)

Welcome investor! Genomictree Inc.'s management wants to use your money to grow the business. In return you get a share of Genomictree Inc..

What can you expect buying and holding a share of Genomictree Inc.?

First you should know what it really means to hold a share of Genomictree Inc.. And how you can make/lose money.

Speculation

The Price per Share of Genomictree Inc. is ₩22,800. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genomictree Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genomictree Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩5,290.79. Based on the TTM, the Book Value Change Per Share is ₩20.29 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-113.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genomictree Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.040.0%-0.070.0%-0.060.0%-0.070.0%-0.070.0%
Usd Book Value Change Per Share-0.110.0%0.010.0%-0.080.0%0.220.0%0.220.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.110.0%0.010.0%-0.080.0%0.220.0%0.220.0%
Usd Price Per Share14.42-11.75-7.50-11.12-11.12-
Price to Earnings Ratio-86.83--48.54--5.65--24.67--24.67-
Price-to-Total Gains Ratio-135.66--82.08-85.88--83.66--83.66-
Price to Book Ratio3.89-3.16-1.85-2.39-2.39-
Price-to-Total Gains Ratio-135.66--82.08-85.88--83.66--83.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.96
Number of shares62
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.22
Usd Total Gains Per Share0.010.22
Gains per Quarter (62 shares)0.8813.51
Gains per Year (62 shares)3.5254.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104-605444
207-2010898
301120162152
401460216206
5018100270260
6021140324314
7025180378368
8028220432422
9032260486476
10035300540530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.016.00.05.9%1.016.00.05.9%1.016.00.05.9%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%7.010.00.041.2%7.010.00.041.2%7.010.00.041.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%7.010.00.041.2%7.010.00.041.2%7.010.00.041.2%

Fundamentals of Genomictree Inc.

About Genomictree Inc.

  • Other

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Genomictree Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genomictree Inc. earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Genomictree Inc. to the Other industry mean.
  • A Net Profit Margin of -211.8% means that ₩-2.12 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genomictree Inc.:

  • The MRQ is -211.8%. The company is making a huge loss. -2
  • The TTM is -292.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-211.8%TTM-292.0%+80.2%
TTM-292.0%YOY-344.9%+52.9%
TTM-292.0%5Y-1,330.4%+1,038.4%
5Y-1,330.4%10Y-1,330.4%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-211.8%5.4%-217.2%
TTM-292.0%5.6%-297.6%
YOY-344.9%6.7%-351.6%
5Y-1,330.4%6.0%-1,336.4%
10Y-1,330.4%6.1%-1,336.5%
1.1.2. Return on Assets

Shows how efficient Genomictree Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genomictree Inc. to the Other industry mean.
  • -1.1% Return on Assets means that Genomictree Inc. generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genomictree Inc.:

  • The MRQ is -1.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-1.6%+0.5%
TTM-1.6%YOY-1.2%-0.4%
TTM-1.6%5Y-1.8%+0.2%
5Y-1.8%10Y-1.8%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.1%1.0%-2.1%
TTM-1.6%1.1%-2.7%
YOY-1.2%1.5%-2.7%
5Y-1.8%1.3%-3.1%
10Y-1.8%1.4%-3.2%
1.1.3. Return on Equity

Shows how efficient Genomictree Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genomictree Inc. to the Other industry mean.
  • -1.1% Return on Equity means Genomictree Inc. generated ₩-0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genomictree Inc.:

  • The MRQ is -1.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-1.9%+0.8%
TTM-1.9%YOY-1.7%-0.2%
TTM-1.9%5Y-2.3%+0.3%
5Y-2.3%10Y-2.3%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.1%3.1%-4.2%
TTM-1.9%3.3%-5.2%
YOY-1.7%5.0%-6.7%
5Y-2.3%3.9%-6.2%
10Y-2.3%3.9%-6.2%

1.2. Operating Efficiency of Genomictree Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genomictree Inc. is operating .

  • Measures how much profit Genomictree Inc. makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genomictree Inc. to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genomictree Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1,571.1%+1,571.1%
5Y-1,571.1%10Y-1,571.1%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%-10.9%
TTM-9.5%-9.5%
YOY-8.9%-8.9%
5Y-1,571.1%6.0%-1,577.1%
10Y-1,571.1%7.2%-1,578.3%
1.2.2. Operating Ratio

Measures how efficient Genomictree Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 6.80 means that the operating costs are ₩6.80 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Genomictree Inc.:

  • The MRQ is 6.798. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.471. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.798TTM7.471-0.673
TTM7.471YOY3.265+4.206
TTM7.4715Y21.710-14.239
5Y21.71010Y21.7100.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7981.259+5.539
TTM7.4711.260+6.211
YOY3.2651.216+2.049
5Y21.7101.257+20.453
10Y21.7101.358+20.352

1.3. Liquidity of Genomictree Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genomictree Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 18.06 means the company has ₩18.06 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Genomictree Inc.:

  • The MRQ is 18.058. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.805. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ18.058TTM11.805+6.253
TTM11.805YOY3.484+8.320
TTM11.8055Y43.465-31.660
5Y43.46510Y43.4650.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ18.0581.434+16.624
TTM11.8051.507+10.298
YOY3.4841.531+1.953
5Y43.4651.478+41.987
10Y43.4651.478+41.987
1.3.2. Quick Ratio

Measures if Genomictree Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genomictree Inc. to the Other industry mean.
  • A Quick Ratio of 9.14 means the company can pay off ₩9.14 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genomictree Inc.:

  • The MRQ is 9.139. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.841. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.139TTM4.841+4.298
TTM4.841YOY1.856+2.986
TTM4.8415Y19.801-14.960
5Y19.80110Y19.8010.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1390.569+8.570
TTM4.8410.604+4.237
YOY1.8560.610+1.246
5Y19.8010.608+19.193
10Y19.8010.603+19.198

1.4. Solvency of Genomictree Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genomictree Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genomictree Inc. to Other industry mean.
  • A Debt to Asset Ratio of 0.06 means that Genomictree Inc. assets are financed with 5.9% credit (debt) and the remaining percentage (100% - 5.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genomictree Inc.:

  • The MRQ is 0.059. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.155. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.155-0.096
TTM0.155YOY0.334-0.180
TTM0.1555Y0.205-0.051
5Y0.20510Y0.2050.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0590.531-0.472
TTM0.1550.527-0.372
YOY0.3340.545-0.211
5Y0.2050.559-0.354
10Y0.2050.570-0.365
1.4.2. Debt to Equity Ratio

Measures if Genomictree Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genomictree Inc. to the Other industry mean.
  • A Debt to Equity ratio of 6.3% means that company has ₩0.06 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genomictree Inc.:

  • The MRQ is 0.063. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.208. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.063TTM0.208-0.145
TTM0.208YOY0.505-0.297
TTM0.2085Y0.292-0.084
5Y0.29210Y0.2920.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0631.082-1.019
TTM0.2081.074-0.866
YOY0.5051.161-0.656
5Y0.2921.294-1.002
10Y0.2921.458-1.166

2. Market Valuation of Genomictree Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Genomictree Inc. generates.

  • Above 15 is considered overpriced but always compare Genomictree Inc. to the Other industry mean.
  • A PE ratio of -86.83 means the investor is paying ₩-86.83 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genomictree Inc.:

  • The EOD is -96.105. Based on the earnings, the company is expensive. -2
  • The MRQ is -86.832. Based on the earnings, the company is expensive. -2
  • The TTM is -48.538. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-96.105MRQ-86.832-9.273
MRQ-86.832TTM-48.538-38.294
TTM-48.538YOY-5.653-42.885
TTM-48.5385Y-24.674-23.864
5Y-24.67410Y-24.6740.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-96.10513.928-110.033
MRQ-86.83210.918-97.750
TTM-48.53810.552-59.090
YOY-5.65311.514-17.167
5Y-24.67412.758-37.432
10Y-24.67412.635-37.309
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genomictree Inc.:

  • The EOD is -42.096. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -38.034. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -34.701. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-42.096MRQ-38.034-4.062
MRQ-38.034TTM-34.701-3.333
TTM-34.701YOY8.863-43.564
TTM-34.7015Y-20.889-13.812
5Y-20.88910Y-20.8890.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-42.0964.634-46.730
MRQ-38.0344.177-42.211
TTM-34.7015.417-40.118
YOY8.8632.561+6.302
5Y-20.8892.216-23.105
10Y-20.8893.950-24.839
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genomictree Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 3.89 means the investor is paying ₩3.89 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Genomictree Inc.:

  • The EOD is 4.309. Based on the equity, the company is fair priced.
  • The MRQ is 3.894. Based on the equity, the company is fair priced.
  • The TTM is 3.162. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.309MRQ3.894+0.416
MRQ3.894TTM3.162+0.732
TTM3.162YOY1.845+1.317
TTM3.1625Y2.389+0.773
5Y2.38910Y2.3890.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD4.3091.697+2.612
MRQ3.8941.299+2.595
TTM3.1621.299+1.863
YOY1.8451.441+0.404
5Y2.3891.487+0.902
10Y2.3891.621+0.768
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Genomictree Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---151.85020.292-848%-113.175-25%311.223-149%311.223-149%
Book Value Per Share--5290.7895291.7590%5795.957-9%4580.567+16%4580.567+16%
Current Ratio--18.05811.805+53%3.484+418%43.465-58%43.465-58%
Debt To Asset Ratio--0.0590.155-62%0.334-82%0.205-71%0.205-71%
Debt To Equity Ratio--0.0630.208-70%0.505-88%0.292-79%0.292-79%
Dividend Per Share----0%-0%-0%-0%
Eps---59.310-102.175+72%-80.135+35%-106.512+80%-106.512+80%
Free Cash Flow Per Share---135.405-122.542-9%30.812-539%-143.112+6%-143.112+6%
Free Cash Flow To Equity Per Share---135.405-122.542-9%30.812-539%-143.112+6%-143.112+6%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6608.595--------
Intrinsic Value_10Y_min---5646.150--------
Intrinsic Value_1Y_max---474.822--------
Intrinsic Value_1Y_min---466.280--------
Intrinsic Value_3Y_max---1569.473--------
Intrinsic Value_3Y_min---1495.465--------
Intrinsic Value_5Y_max---2836.326--------
Intrinsic Value_5Y_min---2620.311--------
Market Cap--486818664400.000384766167857.500+27%218887431572.500+122%266475895521.000+83%266475895521.000+83%
Net Profit Margin---2.118-2.920+38%-3.449+63%-13.304+528%-13.304+528%
Operating Margin----0%-0%-15.7110%-15.7110%
Operating Ratio--6.7987.471-9%3.265+108%21.710-69%21.710-69%
Pb Ratio4.309+10%3.8943.162+23%1.845+111%2.389+63%2.389+63%
Pe Ratio-96.105-11%-86.832-48.538-44%-5.653-93%-24.674-72%-24.674-72%
Price Per Share22800.000+10%20600.00016785.000+23%10720.000+92%15888.500+30%15888.500+30%
Price To Free Cash Flow Ratio-42.096-11%-38.034-34.701-9%8.863-529%-20.889-45%-20.889-45%
Price To Total Gains Ratio-150.148-11%-135.660-82.079-39%85.880-258%-83.662-38%-83.662-38%
Quick Ratio--9.1394.841+89%1.856+393%19.801-54%19.801-54%
Return On Assets---0.011-0.016+49%-0.012+9%-0.018+72%-0.018+72%
Return On Equity---0.011-0.019+73%-0.017+53%-0.023+104%-0.023+104%
Total Gains Per Share---151.85020.292-848%-113.175-25%311.223-149%311.223-149%
Usd Book Value--87522243.80984010568.971+4%82852692.921+6%78502124.706+11%78502124.706+11%
Usd Book Value Change Per Share---0.1060.014-848%-0.079-25%0.218-149%0.218-149%
Usd Book Value Per Share--3.7043.7040%4.057-9%3.206+16%3.206+16%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.042-0.072+72%-0.056+35%-0.075+80%-0.075+80%
Usd Free Cash Flow---2239924.414-1954562.458-13%430763.849-620%-1845586.492-18%-1845586.492-18%
Usd Free Cash Flow Per Share---0.095-0.086-9%0.022-539%-0.100+6%-0.100+6%
Usd Free Cash Flow To Equity Per Share---0.095-0.086-9%0.022-539%-0.100+6%-0.100+6%
Usd Market Cap--340773065.080269336317.500+27%153221202.101+122%186533126.865+83%186533126.865+83%
Usd Price Per Share15.960+10%14.42011.750+23%7.504+92%11.122+30%11.122+30%
Usd Profit---981129.345-1600177.787+63%-1160393.390+18%-1721618.663+75%-1721618.663+75%
Usd Revenue--463203.062598151.640-23%5226493.074-91%1398032.168-67%1398032.168-67%
Usd Total Gains Per Share---0.1060.014-848%-0.079-25%0.218-149%0.218-149%
 EOD+3 -3MRQTTM+17 -15YOY+16 -165Y+21 -1110Y+21 -11

3.2. Fundamental Score

Let's check the fundamental score of Genomictree Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-96.105
Price to Book Ratio (EOD)Between0-14.309
Net Profit Margin (MRQ)Greater than0-2.118
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.139
Current Ratio (MRQ)Greater than118.058
Debt to Asset Ratio (MRQ)Less than10.059
Debt to Equity Ratio (MRQ)Less than10.063
Return on Equity (MRQ)Greater than0.15-0.011
Return on Assets (MRQ)Greater than0.05-0.011
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Genomictree Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.282
Ma 20Greater thanMa 5022,857.500
Ma 50Greater thanMa 10022,215.400
Ma 100Greater thanMa 20020,886.200
OpenGreater thanClose23,200.000
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets132,844,041
Total Liabilities7,812,264
Total Stockholder Equity124,736,301
 As reported
Total Liabilities 7,812,264
Total Stockholder Equity+ 124,736,301
Total Assets = 132,844,041

Assets

Total Assets132,844,041
Total Current Assets95,371,217
Long-term Assets37,472,824
Total Current Assets
Cash And Cash Equivalents 45,269,445
Short-term Investments 47,876,935
Net Receivables 388,287
Inventory 496,531
Other Current Assets 0
Total Current Assets  (as reported)95,371,217
Total Current Assets  (calculated)94,031,198
+/- 1,340,018
Long-term Assets
Property Plant Equipment 17,459,575
Intangible Assets 1,356,755
Long-term Assets Other 0
Long-term Assets  (as reported)37,472,824
Long-term Assets  (calculated)18,816,330
+/- 18,656,495

Liabilities & Shareholders' Equity

Total Current Liabilities5,281,365
Long-term Liabilities2,530,900
Total Stockholder Equity124,736,301
Total Current Liabilities
Short Long Term Debt 1,689,725
Accounts payable 66,788
Other Current Liabilities -1
Total Current Liabilities  (as reported)5,281,365
Total Current Liabilities  (calculated)1,756,513
+/- 3,524,852
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt144,933
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)2,530,900
Long-term Liabilities  (calculated)144,933
+/- 2,385,966
Total Stockholder Equity
Retained Earnings 31,274,127
Total Stockholder Equity (as reported)124,736,301
Total Stockholder Equity (calculated)31,274,127
+/- 93,462,174
Other
Capital Stock12,006,167
Common Stock Shares Outstanding 23,632
Net Invested Capital 126,426,027
Net Working Capital 90,089,852
Property Plant and Equipment Gross 20,734,608



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
116,081,557
116,305,327
118,838,208
113,725,029
125,592,994
127,951,717
123,436,055
117,895,894
118,380,523
178,127,541
179,301,771
177,151,391
194,295,868
176,913,005
176,821,956
162,909,930
163,157,554
140,254,126
137,632,150
132,844,041
132,844,041137,632,150140,254,126163,157,554162,909,930176,821,956176,913,005194,295,868177,151,391179,301,771178,127,541118,380,523117,895,894123,436,055127,951,717125,592,994113,725,029118,838,208116,305,327116,081,557
   > Total Current Assets 
106,405,769
84,333,054
90,345,434
102,058,117
114,403,221
116,162,672
110,888,304
105,300,309
102,942,819
137,587,937
121,348,936
134,327,228
134,283,066
120,675,069
129,083,703
117,999,575
122,579,993
101,696,804
99,007,420
95,371,217
95,371,21799,007,420101,696,804122,579,993117,999,575129,083,703120,675,069134,283,066134,327,228121,348,936137,587,937102,942,819105,300,309110,888,304116,162,672114,403,221102,058,11790,345,43484,333,054106,405,769
       Cash And Cash Equivalents 
106,070,532
10,135,598
44,563,599
42,899,593
62,705,174
69,201,871
51,190,897
56,640,803
50,571,585
62,716,315
48,131,457
66,461,300
63,141,506
42,691,787
47,887,869
67,571,738
66,760,356
78,630,948
59,759,938
45,269,445
45,269,44559,759,93878,630,94866,760,35667,571,73847,887,86942,691,78763,141,50666,461,30048,131,45762,716,31550,571,58556,640,80351,190,89769,201,87162,705,17442,899,59344,563,59910,135,598106,070,532
       Short-term Investments 
0
73,570,287
44,475,648
57,405,958
49,998,585
44,239,424
57,522,510
46,478,324
50,009,887
72,591,338
71,349,631
64,069,925
52,609,812
73,016,679
75,198,737
47,033,387
51,868,370
20,463,730
36,964,899
47,876,935
47,876,93536,964,89920,463,73051,868,37047,033,38775,198,73773,016,67952,609,81264,069,92571,349,63172,591,33850,009,88746,478,32457,522,51044,239,42449,998,58557,405,95844,475,64873,570,2870
       Net Receivables 
40,668
16,465
7,843
40,485
93,249
476,976
340,378
128,373
104,599
47,173
73,410
2,266,748
16,610,290
3,032,176
3,617,512
1,031,114
1,317,595
882,475
717,218
388,287
388,287717,218882,4751,317,5951,031,1143,617,5123,032,17616,610,2902,266,74873,41047,173104,599128,373340,378476,97693,24940,4857,84316,46540,668
       Inventory 
67,514
137,512
236,455
266,531
268,185
1,286,688
1,295,919
1,231,308
1,198,439
1,290,288
950,137
284,867
275,406
605,736
559,611
635,451
626,384
668,738
608,803
496,531
496,531608,803668,738626,384635,451559,611605,736275,406284,867950,1371,290,2881,198,4391,231,3081,295,9191,286,688268,185266,531236,455137,51267,514
   > Long-term Assets 
9,675,787
31,972,273
28,492,774
11,666,912
11,189,773
11,789,045
12,547,752
12,595,585
15,437,705
40,539,604
57,952,836
42,824,162
60,012,803
56,237,936
47,738,253
44,910,355
40,577,562
38,557,322
38,624,730
37,472,824
37,472,82438,624,73038,557,32240,577,56244,910,35547,738,25356,237,93660,012,80342,824,16257,952,83640,539,60415,437,70512,595,58512,547,75211,789,04511,189,77311,666,91228,492,77431,972,2739,675,787
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,079,660
17,866,400
18,011,805
17,958,266
17,976,802
17,459,575
17,459,57517,976,80217,958,26618,011,80517,866,40025,079,66000000000000000
       Goodwill 
0
0
1,120,318
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,120,31800
       Intangible Assets 
1,004,694
996,456
1,034,670
1,042,003
1,061,957
1,043,200
1,011,708
961,918
1,027,179
1,002,206
1,684,648
1,669,419
1,633,796
1,590,888
1,572,466
1,553,917
1,508,313
1,456,709
1,413,746
1,356,755
1,356,7551,413,7461,456,7091,508,3131,553,9171,572,4661,590,8881,633,7961,669,4191,684,6481,002,2061,027,179961,9181,011,7081,043,2001,061,9571,042,0031,034,670996,4561,004,694
       Long-term Assets Other 
9,675,787
0
0
11,666,912
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000011,666,912009,675,787
> Total Liabilities 
2,504,598
3,584,487
4,122,030
4,904,387
19,670,348
24,456,340
23,917,829
22,640,492
23,855,060
66,054,510
65,613,933
62,050,497
65,735,335
58,345,844
58,062,728
55,352,892
55,041,271
21,962,094
9,011,848
7,812,264
7,812,2649,011,84821,962,09455,041,27155,352,89258,062,72858,345,84465,735,33562,050,49765,613,93366,054,51023,855,06022,640,49223,917,82924,456,34019,670,3484,904,3874,122,0303,584,4872,504,598
   > Total Current Liabilities 
637,826
665,369
853,441
1,463,902
1,602,049
4,415,212
3,958,913
4,089,514
3,946,609
4,239,437
1,831,240
2,142,152
18,708,145
54,181,328
55,537,388
53,442,113
53,021,380
17,436,288
4,710,992
5,281,365
5,281,3654,710,99217,436,28853,021,38053,442,11355,537,38854,181,32818,708,1452,142,1521,831,2404,239,4373,946,6094,089,5143,958,9134,415,2121,602,0491,463,902853,441665,369637,826
       Short Long Term Debt 
0
0
0
0
0
0
0
80,000
200,000
300,000
400,000
0
12,532,495
27,655,957
27,942,258
29,042,513
28,975,000
8,747,492
1,625,709
1,689,725
1,689,7251,625,7098,747,49228,975,00029,042,51327,942,25827,655,95712,532,4950400,000300,000200,00080,0000000000
       Accounts payable 
37,962
61,889
137,398
226,217
186,393
296,851
118,338
83,798
81,465
172,191
68,071
87,572
1,819,897
359,284
251,241
132,600
129,707
147,289
110,879
66,788
66,788110,879147,289129,707132,600251,241359,2841,819,89787,57268,071172,19181,46583,798118,338296,851186,393226,217137,39861,88937,962
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
1
2
-1
-1210000-1000000000000
   > Long-term Liabilities 
1,866,772
2,919,118
3,268,589
3,440,485
18,068,300
20,041,129
19,958,917
18,550,979
19,908,451
61,815,073
63,782,693
59,908,345
47,027,190
4,164,517
2,525,340
1,910,780
2,019,891
4,525,806
4,300,856
2,530,900
2,530,9004,300,8564,525,8062,019,8911,910,7802,525,3404,164,51747,027,19059,908,34563,782,69361,815,07319,908,45118,550,97919,958,91720,041,12918,068,3003,440,4853,268,5892,919,1181,866,772
       Long term Debt 
400,000
800,000
800,000
1,200,000
14,404,080
1,600,000
1,600,000
10,331,516
11,451,841
45,062,109
1,753,080
37,270,976
26,608,231
0
0
0
0
0
0
0
000000026,608,23137,270,9761,753,08045,062,10911,451,84110,331,5161,600,0001,600,00014,404,0801,200,000800,000800,000400,000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
1,368,298
1,335,647
1,265,445
1,134,272
1,140,644
1,236,342
1,222,938
1,173,402
1,140,940
1,152,075
1,259,401
137,422
126,248
114,864
103,264
144,933
144,933103,264114,864126,248137,4221,259,4011,152,0751,140,9401,173,4021,222,9381,236,3421,140,6441,134,2721,265,4451,335,6471,368,2980000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000
> Total Stockholder Equity
113,576,959
112,720,840
113,607,029
108,919,499
104,683,445
103,495,377
99,518,226
95,255,402
94,525,464
112,073,031
113,687,838
115,100,893
127,928,924
117,921,368
117,849,536
107,054,759
107,552,318
117,709,798
128,001,486
124,736,301
124,736,301128,001,486117,709,798107,552,318107,054,759117,849,536117,921,368127,928,924115,100,893113,687,838112,073,03194,525,46495,255,40299,518,226103,495,377104,683,445108,919,499113,607,029112,720,840113,576,959
   Common Stock00000000000000000000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 00000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,418,009
Cost of Revenue-3,688,032
Gross Profit-270,022-270,022
 
Operating Income (+$)
Gross Profit-270,022
Operating Expense-20,721,499
Operating Income-17,303,489-20,991,521
 
Operating Expense (+$)
Research Development4,365,793
Selling General Administrative2,894,659
Selling And Marketing Expenses0
Operating Expense20,721,4997,260,452
 
Net Interest Income (+$)
Interest Income3,984,144
Interest Expense-2,054,342
Other Finance Cost-4,558,454
Net Interest Income6,488,256
 
Pretax Income (+$)
Operating Income-17,303,489
Net Interest Income6,488,256
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,503,335-17,303,489
EBIT - interestExpense = -2,054,342
-8,756,037
-6,701,695
Interest Expense2,054,342
Earnings Before Interest and Taxes (EBIT)0-7,448,993
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-9,503,335
Tax Provision--496,609
Net Income From Continuing Ops-9,006,727-9,006,727
Net Income-8,756,037
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-6,488,256
 

Technical Analysis of Genomictree Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genomictree Inc.. The general trend of Genomictree Inc. is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genomictree Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genomictree Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 25,500 < 26,150 < 27,950.

The bearish price targets are: 21,750 > 19,550 > 17,570.

Tweet this
Genomictree Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genomictree Inc.. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genomictree Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genomictree Inc.. The current macd is 275.63.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genomictree Inc. price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Genomictree Inc.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Genomictree Inc. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Genomictree Inc. Daily Moving Average Convergence/Divergence (MACD) ChartGenomictree Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genomictree Inc.. The current adx is 25.29.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genomictree Inc. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Genomictree Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genomictree Inc.. The current sar is 21,176.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Genomictree Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genomictree Inc.. The current rsi is 50.28. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Genomictree Inc. Daily Relative Strength Index (RSI) ChartGenomictree Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genomictree Inc.. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genomictree Inc. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genomictree Inc. Daily Stochastic Oscillator ChartGenomictree Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genomictree Inc.. The current cci is 14.59.

Genomictree Inc. Daily Commodity Channel Index (CCI) ChartGenomictree Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genomictree Inc.. The current cmo is -2.9606664.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Genomictree Inc. Daily Chande Momentum Oscillator (CMO) ChartGenomictree Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genomictree Inc.. The current willr is -72.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Genomictree Inc. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Genomictree Inc. Daily Williams %R ChartGenomictree Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genomictree Inc..

Genomictree Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genomictree Inc.. The current atr is 1,460.

Genomictree Inc. Daily Average True Range (ATR) ChartGenomictree Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genomictree Inc.. The current obv is 48,649,827.

Genomictree Inc. Daily On-Balance Volume (OBV) ChartGenomictree Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genomictree Inc.. The current mfi is 71.47.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Genomictree Inc. Daily Money Flow Index (MFI) ChartGenomictree Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genomictree Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Genomictree Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genomictree Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.282
Ma 20Greater thanMa 5022,857.500
Ma 50Greater thanMa 10022,215.400
Ma 100Greater thanMa 20020,886.200
OpenGreater thanClose23,200.000
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Genomictree Inc. with someone you think should read this too:
  • Are you bullish or bearish on Genomictree Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genomictree Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genomictree Inc.

I send you an email if I find something interesting about Genomictree Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Genomictree Inc..

Receive notifications about Genomictree Inc. in your mailbox!